The value of early intervention in RA—a window of opportunity

Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)

(2009) J Augustsson et al.   ANNALS OF THE RHEUMATIC DISEASES

Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial

(2009) J Kekow et al.   ANNALS OF THE RHEUMATIC DISEASES

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis

(2009) Wilbert B. Van den Hout et al.   ARTHRITIS AND RHEUMATISM

The Gap Between Practice and Guidelines in the Choice of First-line Disease Modifying Antirheumatic Drug in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort

(2009) M. BENHAMOU et al.   JOURNAL OF RHEUMATOLOGY

Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis

(2009) P. EMERY et al.   JOURNAL OF RHEUMATOLOGY

The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study

(2009) A. Anis et al.   RHEUMATOLOGY

Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis

(2008) Victoria Bejarano et al.   ARTHRITIS AND RHEUMATISM

An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis

(2008) A. K. Brown et al.   ARTHRITIS AND RHEUMATISM

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

(2008) Paul Emery et al.   LANCET